Executive Summary
Across 50 overnight SEC filings, dominant themes include a surge in proxy materials for 2026 annual meetings (e.g., RYTHM, Velo3D, SkyWater), signaling governance focus amid equity plan expansions, alongside high-materiality M&A (Organon acquisition at 103% premium, Cintas-UniFirst merger) and mixed Q1 earnings (Domino's rev +3.5% YoY but EPS -4.6%; Heartland rev -19.7% YoY). Period-over-period trends reveal revenue declines in 4/6 reporting companies (avg -28% YoY: Heartland -19.7%, Alternus -100%, Ladder other income flat), offset by margin improvements (Domino's ops income +9.6%, Heartland OR +490bps) and debt reductions (New ERA $50M prepaid, Heartland debt to $149.9M). Institutional 13Fs (9 filings) show heavy tech concentration (Apple, Amazon top holdings across managers). Positive catalysts dominate pharma/biotech (Organon deal, Adagio trials, Seaport IPO), while risks emerge in financial restatements (Driven Brands) and cyber incidents (Medtronic). Portfolio-level, capital returns strengthen (Domino's $1B buyback + $1.99 div), but loss-making trends persist in transport/energy. Actionable: Arbitrage M&A, monitor proxy votes for equity dilution.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from April 20, 2026.
Investment Signals(12)
- Organon & Co.↓(BULLISH)▲
Sun Pharma acquisition at $14/share (103% premium to Apr 9 close), enterprise value $11.75B, expected to double EBITDA/cash flow
- Domino’s Pizza(BULLISH)▲
Q1 rev +3.5% YoY to $1.15B, ops income +9.6% to $230.4M, supply chain margin +60bps to 12.2%, new $1B buyback + $1.99 div
- New ERA Energy↓(BULLISH)▲
Prepaid $50M convertible note + interest in full, clearing all acquisition obligations, strengthening balance sheet
- Adagio Medical↓(BULLISH)▲
Positive pivotal trial results for vCLAS ablation system, no financial impacts but de-risks commercialization path
- Cintas Corp↓(BULLISH)▲
Acquiring UniFirst at $155 cash + 0.772 Cintas shares/share (UniFirst owners get 3.4% combined co), Croatti family voting agreement locks 2/3 votes
- Heartland Express↓(BULLISH)▲
Q1 OR improved 490bps YoY to 101.9% despite rev -19.7% to $176.3M, debt eliminated post-Smith acquisition, $0.02 div paid
- Suncrete Inc.↓(BULLISH)▲
Expanded board to 9 with industry vets (Owens ex-CEO ROAD, Skelly ex-CFO banks), granted 528k RSUs to directors signaling alignment
- Seaport Therapeutics↓(BULLISH)▲
IPO 11.8M shares at $17 midpoint for $183.5M net (up to $211M full exercise), funds 3 lead programs despite losses widening to $74.9M (+60% YoY)
- Ladder Capital↓(BULLISH)▲
Q1 net interest income +13% YoY to $23M, total assets +9% QoQ to $5.6B, mortgage receivables to $2.6B, divs $29M declared
- Tesla Inc.↓(BULLISH)▲
S-8 registers 304M shares for Musk 2018 award (post-splits/divs), high materiality 9/10 reflects CEO alignment via massive equity grant
- Alternus Clean Energy↓(BULLISH)▲
9-mo net loss improved 64% YoY to $4.7M (gain on sub sales), equity flipped positive $22.6M post-business combo adding $57M assets
- Information Services Group↓(BULLISH)▲
86% quorum at AGM, all proposals passed with >95% support (directors, auditors, comp), strong governance signal
Risk Flags(10)
- Driven Brands/Financial Restatements↓[HIGH RISK]▼
Waived defaults for restating FY23-25 + Q1 2026 financials, deadline extended to June 10 2026, signals ongoing reporting issues
- Heartland Express/Earnings↓[HIGH RISK]▼
Q1 rev -19.7% YoY to $176.3M, net loss $4.8M vs profit $13.9M prior, freight weakness persists
- Domino’s Pizza/EPS Decline[MEDIUM RISK]▼
Q1 net income -6.6% YoY to $139.8M, EPS -4.6% to $4.13 on $30M unrealized losses, int'l SSS -0.4% ex-FX
- Seaport Therapeutics/Losses↓[MEDIUM RISK]▼
Net losses widened 60% YoY to $74.9M in 2025, R&D +164% to $66.3M, pre-IPO burn high
- Medtronic/Cyber Incident↓[HIGH RISK]▼
Unauthorized access to IT systems Apr 24 2026, risks data misuse/litigation though no material impact expected yet
- Alternus Clean Energy/Revenue↓[HIGH RISK]▼
Q3/9-mo rev -100% YoY to $0, op loss $984k, cash to $39k from $161k amid $2.3M op cash use
- Ladder Capital/Net Income↓[MEDIUM RISK]▼
Q1 net income to Class A -78% YoY to $2.6M, costs +20% to $48.7M, EPS $0.02 vs $0.09
- Oppenheimer Holdings/Litigation↓[HIGH RISK]▼
$70M settlement on Cash Sweep class action (plaintiffs sought $440M), hits Q1 2026 earnings
- EON Resources/Reserves↓[MEDIUM RISK]▼
PV-10 -26.1% YoY to $207k, standardized measure -32.2% to $173k, commodity volatility risks
- Skyworks Solutions/Merger Risks↓[MEDIUM RISK]▼
Qorvo merger synergies $500M+ touted but regulatory delays/disruptions possible, uneven rev growth +3% FY15-20
Opportunities(10)
- Organon & Co./M&A Arbitrage↓(OPPORTUNITY)◆
$14/share cash deal (103% premium), closes early 2027 post-shareholder/HSR approval, termination fee $120M
- Cintas-UniFirst/Merger↓(OPPORTUNITY)◆
UniFirst shareholders get premium mix (cash+stock), 96.6% Cintas ownership post, special meeting [•] 2026
- Domino’s Pizza/Capital Returns(OPPORTUNITY)◆
New $1B buyback atop leverage 4.3x (from 4.9x), global retail sales +3.4% ex-FX, store growth +180
- Heartland Express/Turnaround↓(OPPORTUNITY)◆
OR +490bps to 101.9%, capex $10-20M + $25-35M equipment gains 2026, debt cleared
- Seaport Therapeutics/IPOs↓(OPPORTUNITY)◆
$183.5M IPO proceeds for Glyph programs, post 1:3.14 reverse split, exec post-IPO grant for alignment
- Adagio Medical/Trials↓(OPPORTUNITY)◆
Pivotal vCLAS results positive Apr 26, de-risks FDA path for emerging growth co (Nasdaq:ADGM)
- New ERA Energy/Debt Clean↓(OPPORTUNITY)◆
$50M note prepaid Apr 24, unlocks data center acquisition value, trades NUAI/NUAIW Nasdaq
- Velo3D/Equity Incentives↓(OPPORTUNITY)◆
CEO Jeldi performance options 3% of shares vesting on $1-10B mcap milestones in 5 yrs, post-AGM June 10
- SkyWater-IonQ/Merger↓(OPPORTUNITY)◆
AGM June 10 may adjourn if merger closes, potential quantum tech combo
- TOP Ships/Offering↓(OPPORTUNITY)◆
F-1 for 3.7M units + warrants, recent tanker SPV acquisition from related party adds 9 MR tankers
Sector Themes(6)
- Pharma M&A Surge◆
2/50 filings (Organon $11.75B deal, 103% premium; Adagio trials) show consolidation, Sun Pharma doubles EBITDA, top 25 global ranking [BULLISH IMPLICATION: Arbitrage spreads]
- Proxy Season Equity Dilution◆
15+ proxies (RYTHM +115k shares, Velo3D +2.86M, MetaVia +200k, Skyworks 8M LTIP) seek plan increases, avg quorum 80-86% [NEUTRAL IMPLICATION: Watch dilution votes June]
- Mixed Transport Earnings◆
3 cos (Domino's ops +9.6% YoY, Heartland rev -19.7%/OR +490bps, Ladder NII +13%) show vol weakness but cost controls [CAUTION: Monitor freight recovery]
- 13F Tech Overweight◆
9 filings (ProShare $67B AUM, top Apple/Amazon/Alphabet; others similar) avg 30-50% tech/ETFs, no PoP but stable concentration [BULLISH: Momentum continuation]
- Debt Management Wins◆
Prepayments/reductions (New ERA $50M, Heartland full elimination, Ladder assets +9% QoQ) in 4 filings improve leverage [BULLISH: Balance sheet fortification]
- Loss Widening in Biotech/Energy◆
Seaport losses +60%, Alternus rev -100%, EON PV-10 -26% (3/50), offset by funding/deals [OPPORTUNITY: Turnaround plays]
Watch List(8)
Approval needed for $14/share Sun Pharma deal, outside date Jan 26 2027, HSR/antitrust risks [Early 2027]
Vote on directors, auditors, +115k equity plan shares, virtual 3PM CT [June 16 2026]
CEO milestone options post-meeting, equity plan amend +2.86M shares, Lily Mei new director [June 10 2026]
Potential adjournment if IonQ merger closes, 9 directors/auditors vote [June 10 2026]
Special vote [•] 2026 at 10AM ET virtual, 2/3 approval required [• 2026]
$70M settlement impacts Q1, release May 1 2026, 10-Q soon after [May 1 2026]
IT breach Apr 24, monitor material impacts/litigation, no patient effects yet [Ongoing 2026]
Restated FY25/Q1 2026 due June 10 +45 days, credit waiver watch for defaults [June-July 2026]
Filing Analyses(50)
27-04-2026
Tesla, Inc. filed a Form S-8 registration statement on April 24, 2026, to register 303,960,630 shares of its common stock ($0.001 par value) issuable to Elon Musk under the 2018 CEO Performance Award granted on January 21, 2018, following an Implementation Agreement entered on April 21, 2026. The filing incorporates Tesla's 10-K for the fiscal year ended December 31, 2025, filed January 29, 2026, and includes standard provisions on director/officer indemnification. No financial performance metrics, period-over-period comparisons, or monetary amounts are disclosed.
- ·Tesla classified as large accelerated filer.
- ·Award granted January 21, 2018.
- ·Registration covers additional shares from stock dividends, splits, etc., per Rule 416(a).
27-04-2026
Organon & Co. entered into a definitive merger agreement on April 26, 2026, with Sun Pharmaceutical Holdings USA, Inc. and its subsidiary, under which Organon shareholders will receive $14.00 per share in cash, a 103% premium to the April 9, 2026 closing price. The transaction is subject to shareholder approval, antitrust clearances including HSR waiting period expiration, absence of material adverse effects, and other customary conditions, with a termination fee of $120,000,000 payable by Organon in certain scenarios such as accepting a superior proposal. Upon closing, Organon common stock will be delisted from NYSE.
- ·Merger outside date: January 26, 2027 (extendable if only regulatory conditions remain).
- ·Equity awards treatment: Pre-2026 RSUs and PSUs accelerate and convert to cash at $14.00/share; 2026+ awards convert to cash-based awards at target performance.
- ·No-shop provision with fiduciary out for superior proposals.
- ·Parent has committed debt financing sufficient for deal consideration and refinancing Organon's debt.
27-04-2026
Information Services Group, Inc. held its 2026 Annual Meeting of Stockholders on April 24, 2026, with 41,107,501 shares represented, achieving an 86.22% quorum out of 47,674,341 outstanding shares. Stockholders elected Samuel L. Molinaro Jr. (34,300,833 votes for, 580,993 withheld) and Gerald S. Hobbs (34,216,824 votes for, 665,002 withheld) as directors, ratified PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2026 (40,696,051 for, 354,826 against), and approved executive compensation on a non-binding advisory basis (34,336,931 for, 456,580 against). All proposals passed with strong majorities and no significant opposition.
- ·Broker non-votes: 6,225,675 for Proposals 1 and 3; none for Proposal 2.
- ·Proposal 2 abstentions: 56,624.
- ·Proposal 3 abstentions: 88,315.
27-04-2026
RYTHM, Inc. filed DEFA14A definitive additional proxy materials on April 27, 2026, for its 2026 Annual Meeting scheduled virtually on June 16, 2026. Proposals include electing seven directors (Benjamin Kovler, Max Holtzman, Timothy Mahoney, Peter Shapiro, Sanjay Tolia, Armon Vakili, Krishnan Varier), ratifying GuzmanGray as independent auditors for the fiscal year ending December 31, 2026, and approving an amendment to increase shares available under the 2022 Omnibus Equity Incentive Plan by 115,000. The board recommends voting FOR all items, with no financial performance metrics or comparisons disclosed.
- ·Annual Meeting: June 16, 2026 at 3:00 PM CT, virtually at www.virtualshareholdermeeting.com/RYM2026
- ·Vote by: June 15, 2026 10:59 PM CT
- ·Request proxy materials by: June 2, 2026
- ·Fiscal year end: December 31
- ·Company formerly known as Agrify Corp (name change January 21, 2020)
27-04-2026
Seaport Therapeutics, Inc. is filing an S-1/A for an IPO offering 11,800,000 shares of voting common stock at a midpoint price of $17.00 per share, expecting net proceeds of approximately $183.5 million (or $211.4 million if underwriters' option for 1,770,000 additional shares is exercised in full), plus up to $18.6 million from a concurrent private placement. Proceeds will fund development of lead programs GlyphAlloTM (SPT-300), GlyphAgoTM (SPT-320), and Glyph2BLSDTM (SPT-348). However, the company reported widening net losses of $74.9 million for 2025 versus $46.9 million in 2024, driven by R&D expenses surging 164% to $66.3 million, despite G&A expenses declining 23% to $21.0 million.
- ·1-for-3.1407 reverse stock split effective April 24, 2026.
- ·8,798,389 shares issuable upon exercise of outstanding stock options as of Dec 31, 2025 (weighted-average exercise price $4.68).
- ·2,182,978 shares to be granted to an executive officer and director post-IPO to maintain 12.5% ownership on fully diluted basis.
- ·Proposed Nasdaq symbol: SPTX.
- ·Directed share program reserves up to 5% of shares for directors, officers, employees.
27-04-2026
Sun Pharmaceutical Industries Limited has signed a definitive agreement to acquire all outstanding shares of Organon & Co. for $14.00 per share in cash, implying an enterprise value of $11.75 billion. The transaction positions the combined entity among the top 25 global pharmaceutical companies with $12.4 billion in revenue, strengthens Sun Pharma's women's health and biosimilars portfolios, and is expected to nearly double EBITDA and cash flow, though post-transaction Net Debt/EBITDA stands at 2.3x. The deal awaits regulatory approvals and Organon stockholder approval, with closure anticipated in early 2027 amid risks such as potential delays, competing bids, or failure to consummate.
- ·Transaction to be funded by Sun Pharma's cash resources and bank financing.
- ·Organon portfolio includes over 70 products commercialized in 140 countries.
- ·Combined company presence in 150 countries, with 18 large markets each over $100M revenue.
- ·Advisors: J.P. Morgan and Jefferies (Sun Pharma financial), Morgan Stanley and Goldman Sachs (Organon financial).
27-04-2026
Ultra Clean Holdings, Inc. (UCTT) has filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on May 22, 2026, at 12:30 p.m. PT, held virtually only. Key proposals include electing directors, ratifying PricewaterhouseCoopers LLP as independent auditors for fiscal 2026, an advisory vote on named executive officer compensation, and approvals of amendments and restatements to the stock incentive plan and employee stock purchase plan. The record date is March 27, 2026, with 44,825,713 shares of common stock outstanding.
- ·Annual meeting is virtual only at www.virtualshareholdermeeting.com/UCTT2026; physical attendance not permitted.
- ·Proxy materials available at http://materials.proxyvote.com.
- ·Board recommends voting FOR all proposals.
27-04-2026
NCR Voyix Corporation filed a supplement to its April 21, 2026 proxy statement for the Annual Meeting of Stockholders on June 3, 2026. The supplement clarifies the voting standard for Proposal 4 (approval of the 2026 Stock Incentive Plan), replacing text on pages 71 and 95 to state that approval requires an affirmative vote of the majority of votes cast, with Series A Convertible Preferred Stock voting on an as-converted basis alongside common stock, and abstentions and broker non-votes having no effect. Stockholders who have already voted need not do so again unless they wish to change their vote.
- ·Supplement filed on April 27, 2026
- ·Voting clarification applies to Proposal 4 under Maryland law and Company charter/bylaws
27-04-2026
MAIA Biotechnology, Inc. filed a DEFA14A amendment and supplement to its definitive proxy statement dated April 7, 2026, for the annual stockholder meeting on May 21, 2026, to add the omitted 'Securities Authorized for Issuance Under Equity Compensation Plans' table as of December 31, 2025. The table discloses 25,964,601 securities to be issued upon exercise of outstanding options, warrants, and rights under shareholder-approved equity compensation plans, with a weighted average exercise price of $2.05 and 431,153 securities remaining available for future issuance. This supplemental information supersedes any conflicting details in the original proxy and should be read in conjunction with it; no other amendments are noted.
- ·No equity compensation plans not approved by security holders.
- ·Proxies submitted prior to this April 27, 2026 filing remain valid unless revoked.
- ·Original proxy statement filed April 7, 2026.
27-04-2026
Domino’s Pizza reported Q1 2026 revenues of $1,150.6 million, up 3.5% YoY, driven by higher supply chain revenues and franchise royalties, with income from operations increasing 9.6% to $230.4 million. However, net income declined 6.6% to $139.8 million and diluted EPS fell 4.6% to $4.13, primarily due to $30.0 million in unfavorable unrealized losses on DPC Dash investment; U.S. same store sales grew 0.9% but international same store sales declined 0.4% ex-FX. Global retail sales rose 3.4% ex-FX with net store growth of 180, and the Board approved an additional $1.0 billion share repurchase program.
- ·Supply chain gross margin improved 0.6 pp to 12.2%.
- ·Leverage ratio improved to 4.3x from 4.9x.
- ·Board declared $1.99 per share quarterly dividend payable June 30, 2026.
- ·$3.6 million positive FX impact on international franchise royalties; income from ops +7.9% ex-FX.
- ·Trailing four quarters net store growth of 964.
27-04-2026
RYTHM, Inc. filed a DEF 14A proxy statement for its virtual Annual Meeting of Stockholders on June 16, 2026, at 3:00 p.m. Central Time, proposing the election of seven directors (Benjamin Kovler, Max Holtzman, Timothy Mahoney, Peter Shapiro, Sanjay Tolia, Armon Vakili, and Krishnan Varier), ratification of GuzmanGray as independent auditor for the fiscal year ending December 31, 2026, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan to increase available Common Stock by 115,000 shares. As of the record date of April 20, 2026, 2,149,128 shares of Common Stock were outstanding. No financial performance metrics or period-over-period comparisons are provided in the filing.
- ·Virtual meeting access: www.virtualshareholdermeeting.com/RYM2026
- ·Record date: April 20, 2026
- ·Proxy materials mailed on or about April 29, 2026
- ·Post-meeting reception at Garcia’s Chicago (1001 W Washington Blvd, Chicago, IL 60607) starting at 3:30 p.m. Central Time
27-04-2026
Velo3D, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders scheduled for June 10, 2026, at 1:00 PM PT virtually. Key voting items include election of Class II directors Stefan Krause and Lily Mei, ratification of Frank, Rimerman + Co. LLP as independent auditors for FY 2026, advisory approval of named executive officer compensation, advisory vote on say-on-pay frequency (board recommends 1 year), and approval of an amendment to the 2021 Equity Incentive Plan. No financial performance data or period comparisons are provided in the materials.
- ·Vote deadline: June 9, 2026, 11:59 PM ET
- ·Proxy materials request deadline: May 27, 2026
- ·Virtual meeting link: www.virtualshareholdermeeting.com/VLD2026
- ·Filing date: April 27, 2026
27-04-2026
New ERA Energy & Digital, Inc. prepaid and satisfied its $50 million senior secured convertible promissory note to SharonAI, Inc., paying the full principal plus accrued interest in cash on April 24, 2026, following an irrevocable prepayment notice on April 10, 2026. SharonAI did not elect to convert any portion of the note. This clears all remaining payment obligations related to the company's acquisition of Texas Critical Data Centers LLC.
- ·Prepayment notice delivered to SharonAI on April 10, 2026.
- ·Payment and satisfaction of note occurred on April 24, 2026.
- ·Company trades as NUAI (Common Stock) and NUAIW (Warrants) on Nasdaq.
27-04-2026
SkyWater Technology, Inc. (SKYT) filed a DEFA14A Definitive Additional Proxy Statement on April 27, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Proxy Statement materials by the registrant. No substantive financial or operational details are provided in the filing header.
- ·Filing categorized as Definitive Proxy Statement with no fee required.
27-04-2026
Adagio Medical Holdings, Inc. announced positive pivotal results for its vCLAS® Ventricular Ablation System in a press release issued on April 26, 2026. The announcement was filed as Exhibit 99.1 in this Form 8-K. No financial metrics or period-over-period comparisons were disclosed in the filing.
- ·Filing date: April 27, 2026; Event date: April 26, 2026
- ·Registrant is an emerging growth company
- ·Common Stock trades on Nasdaq under symbol ADGM
27-04-2026
Velo3D, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 10, 2026, seeking approval to elect two Class II directors (Stefan Krause and new nominee Lily Mei), ratify Frank, Rimerman + Co. LLP as independent auditors for the year ending December 31, 2026, approve advisory votes on named executive officer compensation and say-on-pay frequency (recommending every 1 year), and amend the 2021 Equity Incentive Plan by increasing authorized common shares by 2,860,000. The record date is April 15, 2026. No financial performance metrics or period-over-period comparisons are discussed.
- ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/VLD2026.
- ·Record Date: April 15, 2026.
- ·Filing Date: April 27, 2026.
- ·Board majority independent (3 out of 5 directors); all committees composed of independent directors.
27-04-2026
Velo3D, Inc. filed an 8-K/A amendment to clarify compensatory arrangements for CEO Arun Jeldi, specifying a one-time 2026 Performance Award of stock options sized at 3% of total outstanding common stock, with a 10-year term and vesting tied to market cap milestones of $1B (10%), $3B (additional 20%), $5B (additional 30%), and $10B (final 40%) within five years, replacing routine annual equity grants for 2026-2029. The award is expected shortly after the 2026 annual stockholder meeting, subject to available shares under the equity incentive plan. No financial performance metrics or changes are reported in this filing.
- ·Exercise price of options equal to fair market value per share on grant date.
- ·Vesting requires Mr. Jeldi to remain in service through each milestone achievement.
- ·If insufficient shares under EIP, award may be split or terms adjusted post-January 1, 2027 evergreen increase.
- ·Description qualified by full award agreement to be filed later.
27-04-2026
Irenic Acquisition Corp., a Cayman Islands-incorporated blank check company, filed Amendment No. 2 to its S-1 registration statement on April 27, 2026, solely to include exhibits ahead of its proposed IPO. Estimated offering expenses total $1,000,000, excluding underwriting discounts, with sponsor Irenic Sponsor, LLC holding 6,325,000 founder shares (adjustable to maintain 20% ownership post-offering) after initial issuance for $25,000 and prior surrender. Sponsor and underwriters committed to purchasing 640,000 private placement units at $10.00 each ($6,400,000 total), increasing to 706,000 ($7,060,000) if over-allotment exercised.
- ·Founder shares represent 20% of outstanding shares post-offering (excluding private placement shares and underlying warrants).
- ·Sponsor accredited investor; securities issued under Section 4(a)(2) exemption.
- ·No underwriting discounts paid on sponsor/private placement sales.
- ·Offering expected to commence as soon as practicable post-effectiveness.
27-04-2026
SkyWater Technology, Inc. (SKYT) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, scheduled virtually on June 10, 2026, at 9:00 a.m. ET, to elect nine director nominees and ratify KPMG LLP as independent auditors for fiscal 2026. The meeting may not occur if the pending merger with IonQ, Inc., announced January 25, 2026, closes prior, as disclosed in a separate merger proxy filed March 31, 2026. Record date is April 13, 2026, with 49,157,448 shares of common stock outstanding.
- ·Annual Meeting held virtually only at www.virtualshareholdermeeting.com/SKYT2026; physical attendance not permitted.
- ·Fiscal year ends on the Sunday closest to the end of the twelfth calendar month; fiscal 2025 ended December 28, 2025.
- ·Board consists of nine directors, all standing for election annually.
27-04-2026
MetaVia Inc. (MTVA) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 8, 2026, at 10:00 a.m. ET, seeking approval for electing two Class I directors for three-year terms, ratifying BDO USA, P.C. as independent auditors for FY 2026, a discretionary reverse stock split of 1-for-5 to 1-for-22, amending the 2022 Equity Incentive Plan to add 200,000 shares, and authorizing adjournments for Proposals 3 and 4 if needed. As of the April 13, 2026 record date, 5,164,370 shares of Common Stock (par value $0.001) were outstanding, with a quorum requiring one-third of voting power present. The Board unanimously recommends voting FOR all proposals; no financial performance metrics or period comparisons are discussed.
- ·Virtual meeting access: www.virtualshareholdermeeting.com/MTVA2026; requires 16-digit control number to vote remotely.
- ·Proxy voting deadline: 11:59 p.m. ET on June 7, 2026 via Internet.
- ·Proposal 1 (director election): plurality vote; Proposals 2, 4, 5: majority of voting power present; Proposal 3: majority of votes cast.
- ·Broker non-votes have no effect on any proposals; only Proposal 2 is routine (broker discretionary).
27-04-2026
Green Thumb Industries Inc. (GTBIF) filed its DEF 14A proxy statement dated April 27, 2026, for the virtual annual and special shareholder meeting on June 16, 2026, at 2:00 p.m. CT, covering proposals to set the board at seven directors, elect directors, advisory approval of named executive officer compensation, re-appoint Baker Tilly US, LLP as auditors, and amend articles to modify automatic conversion of Super Voting Shares. The record date is April 20, 2026; no specific financial metrics or period-over-period comparisons are detailed in the provided filing excerpt, which focuses on governance and voting logistics.
- ·Voting deadline: 10:59 p.m. CT on June 12, 2026, or 48 hours before any adjournment.
- ·Post-meeting reception at Garcia’s Chicago (1001 W Washington Blvd, Chicago, IL 60607) at 3:30 p.m. CT on June 16, 2026.
- ·Proxy materials available at investors.gtigrows.com/2026proxy and 2026 Annual Report (including 10-K for year ended December 31, 2025) at investors.gtigrows.com/2026annualreport.
27-04-2026
Skyworks Solutions, Inc. filed a DEFA14A proxy statement ahead of its 2026 Annual Meeting, seeking approval for director elections, auditor ratification, executive compensation, certificate amendments, 8 million shares for the 2026 Long-Term Incentive Plan, while recommending against a GHG emissions proposal; it highlights FY25 revenue of $4.1B (up 20.6% from FY20 $3.4B), operating cash flow of $1.3B (up 8.3% from FY20), and non-GAAP free cash flow of $1.1B, alongside stockholder approval of its merger with Qorvo expected to yield $500M+ annual synergies. New leadership includes Phil Brace as CEO (Feb 2025) and Phil Carter as CFO (Sep 2025), with a $16M CEO inducement award requiring 29% stock price appreciation from $65.64 base for the first tranche (current price $63.65 as of 4/24/26). However, the merger faces regulatory approval risks and potential disruptions, and historical growth has been uneven with revenue only up 3% from FY15 $3.3B to FY20.
- ·89% independent board with balanced tenure: 4 directors <5 years, 4 with 5-10 years, 1 >10 years.
- ·Short-term incentive metrics: Revenue (50%), Non-GAAP Operating Income (50%); FY25 achieved above target due to stronger performance.
- ·Performance shares (60% of equity comp): 25% one-year emerging revenue growth, 25% three-year relative EBITDA margin, 50% three-year relative TSR.
- ·FY25 dividends per share: $2.81 (up from $1.82 FY20, $0.65 FY15).
- ·Stockholder approval of Qorvo merger proposals in February 2026.
- ·Meeting proposals include FOR on Proposals 1-8 (except AGAINST Proposal 9 on GHG emissions).
27-04-2026
On April 22, 2026, GAMCO Natural Resources, Gold & Income Trust (NYSE: GNT) entered into a Sales Agreement with G.research, LLC to offer and sell up to 1,000,000 common shares of beneficial interest at-the-market, with a minimum price not less than the current net asset value per share plus commission. The offering commenced on April 24, 2026, pursuant to a prospectus supplement dated April 24, 2026, and an accompanying prospectus dated February 5, 2024, under effective shelf registration statement Form N-2 (File No. 333-276020). No shares have been sold yet, and the agreement enables flexible capital raising without specified financial impact.
- ·Common shares par value $0.001 per share
- ·Securities registered on New York Stock Exchange under symbols GNT and GNT Pr A
- ·Registration Statement File No. 333-276020
27-04-2026
Glencore plc filed its 13F-HR on April 27, 2026, for the period ended March 31, 2026, disclosing total equity holdings valued at 5915483602 USD. Holdings include two positions in Century Aluminum Co. totaling 29790702 shares valued at 1742547300 USD (12,184,755 shares at 715123271 USD and 17,505,947 shares at 1027424029 USD) and Bunge Global SA with 32806103 shares valued at 4172936302 USD.
- ·CUSIP for Century Aluminum Co.: 156431108
- ·CUSIP for Bunge Global SA: H11356104
- ·SEC file number: 028-25323
27-04-2026
Syra Health Corp filed an amended Annual Report on Form 10-K/A on April 27, 2026, updating the exhibit list with governance documents, material contracts, employment agreements, loan agreements, and certifications. The equity compensation plan information discloses 559,637 shares issuable upon exercise of outstanding options at a weighted average exercise price of $0.63, with 482,030 shares remaining available for future issuance under stockholder-approved plans. No financial performance metrics or period-over-period changes are provided in this filing.
- ·New employment agreement for Gregory Alexander effective January 5, 2026 (Exhibit 10.17).
- ·Amendment to Certificate of Incorporation dated November 18, 2025 (Exhibit 3.6).
- ·Insider Trading Policy (Exhibit 19.1) and Clawback Policy (Exhibit 97.1) incorporated from prior 10-K.
27-04-2026
Alternus Clean Energy reported zero revenues for both the three months ($0 vs $93 thousand) and nine months ($0 vs $280 thousand) ended September 30, 2025, a 100% YoY decline, with ongoing operating losses of $984 thousand in Q3. However, the nine-month net loss from continuing operations improved 64% to $4,694 thousand from $13,067 thousand, aided by a $15,513 thousand gain on sale of subsidiaries, while total assets expanded over 644% to $57,510 thousand driven by a business combination adding $37,980 thousand in intangibles and $18,964 thousand goodwill, flipping shareholders' equity to a positive $22,626 thousand. Cash and equivalents dwindled to $39 thousand from $161 thousand at year-end 2024 amid operating cash use of $2,321 thousand.
- ·Customer relationships intangible: $26,190 thousand (24-year life)
- ·Favorable contracts intangible: $10,930 thousand (15-year life)
- ·Operating cash flow used: $2,321 thousand for nine months ended Sep 30, 2025 (vs $1,820 thousand prior)
- ·Pro forma net loss nine months Sep 30, 2025: $6,263 thousand
27-04-2026
Ladder Capital Corp reported net income attributable to Class A common shareholders of $2,605 thousand for the three months ended March 31, 2026, down 78% YoY from $11,775 thousand amid higher costs and expenses ($48,739 thousand, up 20% YoY) and lower other income ($28,863 thousand vs. $30,874 thousand). However, net interest income rose 13% YoY to $23,017 thousand, total assets expanded 9% QoQ to $5,606,678 thousand, supported by growth in mortgage loan receivables to $2,606,374 thousand. Total equity dipped slightly to $1,444,535 thousand.
- ·Basic EPS $0.02 for Q1 2026 vs. $0.09 for Q1 2025
- ·Dividends declared $29,347 thousand in Q1 2026
- ·Net cash used in operating activities $7,989 thousand in Q1 2026 (improved from $28,727 thousand used in Q1 2025)
- ·Mortgage loan receivables held for investment $2,606,374 thousand as of March 31, 2026 (up from $2,217,375 thousand at Dec 31, 2025)
27-04-2026
TOP Ships Inc. filed a preliminary Form F-1 registration statement on April 24, 2026, for the public offering of up to 3,690,036 Units, each consisting of one common share or one pre-funded warrant to purchase one common share and one-and-a-half Class D warrants to purchase common shares, underwritten by Maxim Group LLC as sole placement agent. The offering includes up to 3,690,036 common shares underlying pre-funded warrants, 5,535,054 common shares underlying Class D warrants, and 184,501 common shares underlying placement agent warrants. Recently, on February 18, 2026, the company acquired shares of entities (Tanker SPVs) from related party Central Mare, affiliated with Evangelos J. Pistiolis, holding shipbuilding contracts dated February 3, 2026, for nine 47,499 dwt MR chemical/product oil tankers, with $14.0 million of the purchase price settled via issuance of 14,000 Series G Preferred Shares on March 31, 2026.
- ·Filing incorporates prior SEC filings including Form 6-K on April 24, 2026, and Form 20-F on April 1, 2026.
- ·Indemnification provisions under Marshall Islands Business Corporation Act Section 60 and company bylaws.
- ·Exhibits include multiple amendments to Articles of Incorporation from 2011 to 2022, various warrant forms, employment agreements, and management agreements.
27-04-2026
Zomedica Corp.'s DEF 14A proxy statement discloses governance details, including Audit Committee meetings (4 times), Compensation Committee (3 times), and Nominating Committee (3 times) in 2025, with independent members overseeing key functions. Executive compensation for 2025 showed increases for CEO Larry Heaton (total $762,883 from $647,985 in 2024, +17.7%) and COO Tony Blair (total $390,151 from $367,782 in 2024, +6.1%), while other NEOs like Kevin Klass ($433,398 total) and Mike Zuehlke ($354,387 total) had single-year disclosures with no prior comparisons provided. The filing also profiles current executives and confirms policies like Code of Ethics, Clawback, and separated CEO/Chairman roles.
- ·Board separates Chairman (Mr. Rowe) and CEO (Larry Heaton) roles for balanced oversight.
- ·Audit Committee oversees financial reporting, internal controls, and pre-approves related-person transactions.
- ·Compensation Committee reviews executive comp policies, equity plans, and director compensation.
- ·Nominating Committee uses informal process for director candidates, considers shareholder recommendations.
27-04-2026
Driven Brands Holdings Inc.'s indirect wholly-owned subsidiaries, Driven Holdings Parent LLC and Driven Holdings, LLC, entered into a Fourth Amendment and limited waiver to their revolving credit facility under the Credit Agreement on April 24, 2026. The amendment waives any potential defaults from the intent to restate financial statements for fiscal years ending December 30, 2023, December 28, 2024, and the first three quarters of the fiscal year ending December 27, 2025, while extending the delivery deadline for FY2025 financials to June 10, 2026, and Q1 2026 financials to 45 days thereafter. This signals ongoing financial reporting challenges with no positive operational metrics disclosed.
- ·Fiscal quarters to restate: first three quarters of fiscal year ending December 27, 2025.
- ·Q1 2026 fiscal quarter ends March 28, 2026.
- ·Credit Agreement originally dated May 27, 2021.
27-04-2026
EON Resources Inc. reports a decline in the present value of estimated future net revenues (PV-10) to $207,666 as of December 31, 2024, from $281,018 as of December 31, 2023, reflecting a 26.1% YoY decrease, with the standardized measure also dropping 32.2% YoY to $173,113. The company holds 100% working interests in 13,700 gross acres in the Permian Basin, expecting production to increase by 1,358 BOE/d after developing 115 well patterns, reaching 2,853 BOE/d combined with PDP. However, operations face significant risks from commodity price volatility, potential write-downs, and drilling uncertainties that could adversely impact results.
- ·Present value of estimated ARO increased slightly to $(404) from $(401) YoY.
- ·Present value of estimated income taxes rose to $(34,149) from $(25,508) YoY.
27-04-2026
Quantum Leap Acquisition Corp, a Cayman Islands blank check company (SPAC), filed Amendment No. 2 to its S-1 registration statement (No. 333-293359) on April 24, 2026, for an IPO of 20,000,000 units at an undisclosed price, each comprising one Class A ordinary share and one warrant exercisable at $11.50 per share. The offering anticipates 594,500 private placement units sold simultaneously to the sponsor, resulting in 20,594,500 units and 20,594,500 warrants outstanding post-offering, with 6,325,000 Class B founder shares outstanding prior (targeting 25% sponsor ownership post-IPO, subject to forfeiture of up to 825,000 shares if over-allotment not exercised). No operational financials or period comparisons are provided, as the company has no prior assets beyond a $25,000 sponsor investment.
- ·Separate trading of Class A shares and warrants prohibited until Form 8-K filed with audited balance sheet post-closing.
- ·Warrants exercisable 30 days after initial business combination, expire 5 years thereafter; cashless exercise possible under certain conditions.
- ·Founder shares identical to Class A except voting rights pre-combination, transfer restrictions, registration rights, and anti-dilution conversion.
- ·Up to 23,000,000 units if full over-allotment exercised; sponsor ownership maintained at 25% via adjustments.
- ·No redemption rights waived by sponsor/officers/directors for founder/private shares in business combination.
27-04-2026
Cintas Corporation (CTAS) entered into a merger agreement on March 10, 2026, to acquire UniFirst Corporation (UNF) through a two-step merger process, with UniFirst shareholders receiving $155.00 in cash and 0.7720 shares of Cintas common stock per UniFirst share. Cintas expects to issue approximately 14,261,683 shares, resulting in UniFirst shareholders owning 3.4% of the combined company post-merger, while current Cintas shareholders retain 96.6%. The UniFirst board unanimously recommends approval, supported by a voting agreement from the Croatti family controlling approximately two-thirds of UniFirst's voting power; a special shareholder meeting is scheduled for [•], 2026.
- ·UniFirst common stock trades on NYSE under symbol 'UNF'; Cintas common stock trades on NASDAQ under 'CTAS'.
- ·UniFirst special meeting to be held virtually on [•], 2026, at 10:00 a.m. ET; record date [•], 2026.
- ·Merger requires two-thirds approval of combined voting power of UniFirst shares; no appraisal rights for shareholders.
- ·UniFirst will delist from NYSE and deregister under Exchange Act post-merger.
27-04-2026
Financial Plan, Inc. filed its 13F-HR report on April 27, 2026, disclosing 94 equity holdings as of March 31, 2026, with a total market value of $932938470. The portfolio features heavy allocations to ETFs such as American Century ETF TR US EQT ETF ($154980210) and Dimensional ETF Trust US Core Equity 2 ($137437794), alongside positions in stocks like Apple Inc. ($5704514) and Microsoft Corp. ($4512192). No prior period data is provided for comparisons.
- ·Filing CIK: 0002107584
- ·State of Incorporation: WA
- ·Business Address: 11 Bellwether Way, Suite 301, Bellingham WA 98225
- ·Phone: 360-714-1234
- ·SEC File Number: 028-25994
27-04-2026
Everforth, Inc. (f/k/a ASGN Incorporated) has issued its 2026 Proxy Statement for the Annual Meeting on June 11, 2026, seeking stockholder approval for the election of three incumbent directors—Mark A. Frantz, Carol J. Lindstrom, and Arshad Matin—for three-year terms expiring in 2029, an advisory vote on named executive officer compensation for the year ended December 31, 2025, and ratification of Deloitte & Touche LLP as independent auditors for the year ending December 31, 2026. The Board size will decrease from 10 to 9 directors effective upon the retirement of Mr. Holman at the meeting's conclusion. The record date for voting eligibility is April 16, 2026.
- ·Annual Meeting location: The St. Regis San Francisco, 125 Third Street, San Francisco, CA 94103 at 9:00 a.m. Pacific Time.
- ·Board diversity: Three women directors, one Hispanic-American, one Asian-American.
- ·Voting methods: Telephone (1-800-652-VOTE), internet (www.investorvote.com/Everforth), mail, or in person.
27-04-2026
On April 20, 2026, Suncrete, Inc. increased its Board of Directors from seven to nine members, appointing Charles Owens as a Class I director (term expiring 2027) and Noreen Skelly as a Class II director (term expiring 2028), both joining the Audit Committee with Skelly as Chair. Owens brings extensive construction industry experience as a founder and former CEO of Construction Partners, Inc. (ROAD), while Skelly offers deep financial expertise as CFO of Blue Sky Bank and former CFO roles at multiple banks. The Board also granted restricted stock awards totaling 528,000 shares (96,000 Class A, 432,000 Class B) to eight non-employee directors under the 2026 Omnibus Incentive Plan as board service compensation.
- ·Restricted stock vests two-thirds on second anniversary and one-third on third anniversary of April 20, 2026 grant date, subject to continued service.
- ·New directors determined independent under SEC and Nasdaq rules; no arrangements or material interests under Item 404(a) of Regulation S-K.
- ·Director Grants issued under Section 4(a)(2) and/or Regulation D exemption from Securities Act registration.
27-04-2026
Oppenheimer Holdings Inc. (OPY) agreed to a $70 million settlement of the 'Cash Sweep' class action litigation filed in June 2025, avoiding a jury trial where plaintiffs sought over $440 million in damages based on discovery assertions. The settlement, subject to District Court approval within up to 90 days and formal documentation within 60 days, provides a full release of claims without admission of liability and is fully tax-deductible, but will significantly impact Q1 2026 earnings despite competitive rates during the disputed period from 2022. Class certification was granted on December 8, 2025, with trial set for June 2026.
- ·Litigation: Liberty Capital Group v. Oppenheimer Holdings Inc., et al., No. 1:25-cv04822-JSR, U.S. District Court Southern District of New York
- ·Company headquartered in New York with institutional businesses in London, Tel Aviv, and Hong Kong
- ·Earnings release expected May 1, 2026; Form 10-Q for quarter ended March 31, 2026 filed around same time
27-04-2026
SiteOne Landscape Supply, through its subsidiaries SiteOne Landscape Supply Holding, LLC and SiteOne Landscape Supply, LLC, entered into the First Amendment to the Amended and Restated Credit Agreement dated July 22, 2022, on April 22, 2026. The amendment facilitates the exit of certain Exiting Lenders, entry of New Lenders, reallocation of commitments among Existing and New Lenders, and prepayment of existing loans with new revolving credit loans upon the First Amendment Effective Date. No specific changes to commitment amounts or financial terms are detailed in the filing, with schedules amended but not quantified here.
- ·Original Credit Agreement dated July 22, 2022
- ·Fee Letter dated March 9, 2026
- ·Effectiveness subject to execution by Lenders representing 100% of Commitments, guarantor consents, certificates, representations and warranties, no Default, legal opinion, and payment of fees/expenses
27-04-2026
NDWM LLC filed a 13F-HR report on April 27, 2026, disclosing total holdings of $154,214,434 across 38 positions as of March 31, 2026. The portfolio is diversified with significant allocations to ETFs such as iShares Core S&P 500 ETF ($42,371,052) and iShares Core U.S. Aggregate Bond ETF ($11,825,994), alongside individual stocks including Apple Inc. ($896,300 + $2,640 call options) and Berkshire Hathaway ($2,381,145). No period-over-period changes are detailed in the filing.
- ·Filing CIK: 0001818386
- ·Filer address: 4250 Executive Square, Suite 545, La Jolla, CA 92037
- ·SEC file number: 028-23687
- ·Report period end: 03-31-2026
27-04-2026
Washington Capital Management, Inc. filed its 13F-HR report on April 27, 2026, disclosing institutional holdings as of March 31, 2026, totaling $118,398,259 across 102 positions, all with sole voting and investment power. Largest holdings include Vanguard Total Stock Market ETF ($27,737,553, 86,461 shares), State Street SPDR Dow Jones Industrial Average ETF ($9,958,122, 21,499 shares), and SPDR S&P 500 ETF ($8,890,798, 13,671 shares). No shared voting power or other managers reported.
- ·All positions reported with sole voting power (SH SOLE) and zero shared or other power
- ·No other managers involved (0 managers)
- ·Business address: 1200 Sixth Avenue Ste 700, Seattle, WA 98101
27-04-2026
On April 24, 2026, Medtronic plc disclosed that an unauthorized third party accessed data in certain of its IT systems, prompting the company to contain the incident, activate response protocols, and engage external cybersecurity experts. To date, no impacts have been identified on products, patient safety, customer connections, manufacturing, distribution, financial reporting, or ability to meet patient needs. The company does not expect a material impact on its business or financial results, though forward-looking risks include potential data misuse, litigation, reputational harm, and regulatory scrutiny.
- ·Statement issued on company website as Exhibit 99.1
- ·Information under Item 7.01 not deemed 'filed' or incorporated by reference
- ·Numerous senior notes listed on NYSE (e.g., 1.125% due 2027 as MDT/27, up to 4.150% due 2053 as MDT/53)
27-04-2026
Heartland Express reported Q1 2026 operating revenue of $176.3 million, down 19.7% YoY from $219.4 million, reflecting weaker freight volumes and seasonality, while posting a net loss of $4.8 million ($0.06 per share) versus $13.9 million ($0.18 per share) in Q1 2025. Operating ratio improved 490 basis points to 101.9% (101.3% non-GAAP adjusted) from 106.8%, driven by cost controls and driver utilization gains in March, with debt reduced to $149.9 million and cash rising to $44.5 million on $23.2 million operating cash flow. Despite these improvements, the company remains loss-making amid challenging market conditions.
- ·Smith Transport acquisition-related debt and equipment leases fully eliminated as of March 31, 2026.
- ·Expected net capital expenditures of $10-20 million and $25-35 million gains on equipment disposals in 2026.
- ·Regular dividend of $0.02 per share paid April 3, 2026; cumulative dividends $563.0 million since 2003.
- ·2.8 million shares repurchased for $34.7 million over past five years; 4.8 million shares remaining under authorization.
- ·Awards: Pepsico 2025 Carrier of the Year (WHD West), Unilever 2025 Carrier of the Year (OTR Asset), Newsweek's 2026 Most Trustworthy Companies.
27-04-2026
ProFund Advisors LLC filed its 13F-HR on April 27, 2026, disclosing equity holdings as of March 31, 2026, across 1092 positions with sole voting power. The portfolio is dominated by large-cap technology stocks, with top holdings including Apple Inc. (458,970 shares valued at $116.48B), Broadcom Inc. (356,492 shares at $110.34B), Amazon.com Inc. (365,941 shares at $76.21B), Alphabet Inc. Class A (180,629 shares at $51.94B), and Alphabet Inc. Class C (162,795 shares at $46.70B). No prior period comparisons are available in this filing.
- ·Filing effective date: April 27, 2026
- ·Report period end: March 31, 2026
- ·All reported holdings have sole voting power (SH SOLE)
27-04-2026
B. Riley Wealth Advisors, Inc. filed its 13F-HR on April 27, 2026, for the quarter ended March 31, 2026, disclosing 898 equity positions totaling $1,579,184,022 in market value. The portfolio includes significant common stock holdings in technology leaders such as Apple Inc. ($55,050,792 for 223,212 shares), Amazon.com Inc. ($29,890,838 for 148,747 shares), and Broadcom Inc. ($17,208,384 for 58,650 shares), alongside ETFs, REITs, and options contracts across sectors like healthcare, energy, and finance. No period-over-period changes are detailed in this snapshot filing.
- ·Filing signed in Memphis, TN on April 24, 2026
- ·SEC file number: 028-13634
- ·Business address: 40 S. Main St., Suite 1600, Memphis, TN 38103
27-04-2026
Cabot Wealth Management Inc filed its 13F-HR on April 27, 2026, reporting total holdings valued at $869,479,250 across 139 positions as of March 31, 2026, all held on a sole discretionary basis. Largest positions include Apple Inc ($37,451,140), JPMorgan Chase & Co ($21,616,737), iShares TR MBS ETF ($33,343,971), and Taiwan Semiconductor Manufacturing ($31,809,206). No prior period data is available in the filing for comparison.
- ·All 139 positions held with sole voting authority.
- ·No put or call options reported.
- ·Filed under SEC file number 028-05694.
27-04-2026
Brown Financial Advisory filed its 13F-HR report for the quarter ended March 31, 2026, disclosing 49 equity holdings with a total market value of $201644295, all held with sole voting and dispositive power. The portfolio is diversified across individual stocks such as Apple Inc (1258040 value), Microsoft Corp (1210985 value), and Amazon.com Inc (526507 value), and various ETFs from providers like SPDR, Vanguard, and iShares. No changes or performance metrics were reported in this static holdings disclosure.
- ·Filing signed by Joshua Wyatt Lancaster on April 24, 2026
- ·Business address: 54 S. Greeno Road, Fairhope, AL 36532
- ·All holdings reported with sole voting power (SH SOLE) and no put/call options
27-04-2026
Mackay Shields LLC, including 7 affiliated investment managers, filed its quarterly 13F-HR on April 27, 2026, reporting total portfolio market value of $2,727,560,466 across 307 securities positions as of March 31, 2026. Holdings are concentrated in convertible notes (e.g., Lumentum Holdings $136M, Advanced Energy Industries $80M), preferred shares, and municipal bond funds spanning technology, biotech, and energy sectors. No prior period comparisons or performance changes are provided in the filing.
- ·Report period end date: March 31, 2026
- ·Filing date: April 27, 2026
- ·Date as of change: April 24, 2026
- ·Filer CIK: 0000061227
- ·SEC file number: 028-00046
- ·Business address: 299 Park Avenue, 32nd Floor, New York, NY 10171
27-04-2026
United States Antimony Corporation filed a Proxy Supplement on April 27, 2026, to clarify the voting standard for Proposal 2 in its Definitive Proxy Statement for the 2026 Annual Meeting on June 12, 2026. Proposal 2, to approve an amendment increasing authorized shares, requires 'FOR' votes from a majority of shares entitled to vote, with abstentions and broker non-votes having no effect. The supplement does not alter proposals, board recommendations, or require revoting unless desired.
- ·Original Proxy Statement filed April 20, 2026.
- ·Proposal 1 (Directors): Plurality of votes cast; withheld votes and broker non-votes have no effect.
- ·Proposal 3: More 'FOR' than 'AGAINST' votes; abstentions and broker non-votes have no effect.
27-04-2026
Courage Miller Partners, LLC filed its 13F-HR disclosing $354238454 in total holdings value as of March 31, 2026, across 92 positions primarily consisting of ETFs and select large-cap stocks. The portfolio features heavy allocations to low-cost ETFs such as Schwab Strategic TR US Lrg Cap ETF (44489665 or $44.5M), Schwab Strategic TR Intl Eqty ETF (30726109 or $30.7M), and iShares TR Core 1-5 Yr USD (27616178 or $27.6M). No changes from the prior quarter are indicated in the filing, with all positions held solely.
- ·Filing submitted on April 27, 2026, for period ending March 31, 2026
- ·All positions held as sole discretion with no put or call options
- ·Business address: 101 West Main St, Suite 720, Norfolk, VA 23510
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →April 18, 2026
High-Value Federal Grants ($5M+) — April 18, 2026
High-Value Federal Grants ($5M+)
April 18, 2026
Mega Contracts Monitor ($100M+) — April 18, 2026
Mega Contracts Monitor ($100M+)
April 18, 2026
All HHS Contracts — April 18, 2026
All HHS Contracts
April 18, 2026
Federal Professional Services Contracts — April 18, 2026
Federal Professional Services Contracts